Author(s): Ferreira, Grazielle M. [UNESP] ; Martinez, Marcelo ; Camargo, Isabel Cristina Cherici [UNESP] ; Domeniconi, Raquel F. [UNESP] ; Martinez, Francisco Eduardo [UNESP] ; Chuffa, Luiz Gustavo de Almeida [UNESP]
Date: 2015
Persistent ID: http://hdl.handle.net/11449/126772
Origin: Oasisbr
Subject(s): Ovarian cancer; Melatonin; Her-2; p38 MAPK; p-AKT; mTOR
Made available in DSpace on 2015-08-21T17:53:08Z (GMT). No. of bitstreams: 0 Previous issue date: 2014. Added 1 bitstream(s) on 2015-08-24T14:41:51Z : No. of bitstreams: 1 ISSN1837-9664-2014-05-09-728-735.pdf: 1433916 bytes, checksum: 66899a205503d3f5a049c45e7cc71975 (MD5)
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Epidermal growth factor receptors 2 (Her-2) and 4 (Her-4) are closely associated with ovarian cancer (OC) progression and metastasis, and a more complete understanding of these signaling pathways allow the development of new therapeutic strategies. Melatonin (Mel) is recognized as having several anticancer properties and has been reported to modulate Her-2 system in aggressive tumors. Here, we investigated OC and the role of Mel therapy on the Her-2- and Her-4-signaling pathway related to downstream molecules in an ethanol-preferring rat model. To induce OC, the left ovary was injected directly with a single dose of 100 µg 7,12-dimethylbenz(a)anthracene (DMBA) dissolved in 10 µL of sesame oil under the bursa. Right ovaries were used as sham-surgery controls. After developing OC, half of the animals received i.p. injections of Mel (200 µg/100 g b.w./day) for 60 days. While Mel therapy was unable to reduce Her-4 and phosphoinositide 3-kinase (PI3K) levels, it was able to suppress the OC-related increase in the levels of the Her-2, p38 mitogen-activated protein kinases (p38 MAPK), protein kinase B (phospho-AKT), and mammalian target of rapamycin (mTOR). In addition, Mel significantly attenuated the expression of Her-2, p38 MAPK, and p-AKT, which are involved in OC signaling during ethanol intake. Collectively, our results suggest that Mel attenuates the Her-2-signaling pathway in OC of ethanol-preferring rats, providing an effective contribution for further development of adjuvant therapies.
Department of Morphology and Pathology, UFSCar - Universidade Federal de São Carlos, São Carlos-SP, Brazil, 13565-905.
Universidade Estadual Paulista Júlio de Mesquita Filho, Departamento de Ciências Biológicas, Faculdade de Ciências e Letras de Assis, Assis, Av. Dom Antonio,2100 - Laboratório de Histologia e Embriologia, Jardim Universitário, CEP 19806900, SP, Brasil
Department of Anatomy, Biosciences Institute, UNESP - Univ. Estadual Paulista, Botucatu-SP, Brazil, 18618-970
Department of Biological Sciences, Faculty of Sciences and Letters, UNESP - Univ. Estadual Paulista, Assis-SP, Brazil, 19806-900.
FAPESP: 2013/10309-9
FAPESP: 2013/02466-7
